Cystatin C predicts renal function impairment after partial or radical tumor nephrectomy.

Mike WenzelHang YuAnnemarie UhligChristoph WürnschimmelManuel WallbachAndreas BeckerMargit FischFelix K H ChunChristian P MeyerMarianne Leitsmann

Published in: International urology and nephrology (2021)

Preoperative CysC predicts renal function impairment following RCC surgery. Furthermore, CysC might be superior to creatinine for renal function monitoring in the early postoperative setting.

Keyphrases

patients undergoing
minimally invasive
coronary artery bypass
robot assisted
renal cell carcinoma
uric acid
surgical site infection
metabolic syndrome
percutaneous coronary intervention